NGF/TRKA Decrease MiR-145-5p Levels in Epithelial Ovarian Cancer Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Oct 21

PMID 33081171

Citations 18

Authors

Maritza P Garrido

Ignacio Torres

Alba Avila

Jonas Chnaiderman

Manuel Valenzuela-Valderrama

Jose Aramburo

Lorena Orostica

Eduardo Duran-Jara

Lorena Lobos-Gonzalez

Carmen Romero

Affiliations

Soon will be listed here.

Abstract

Nerve Growth Factor (NGF) and its high-affinity receptor tropomyosin receptor kinase A (TRKA) increase their expression during the progression of epithelial ovarian cancer (EOC), promoting cell proliferation and angiogenesis through several oncogenic proteins, such as c-MYC and vascular endothelial growth factor (VEGF). The expression of these proteins is controlled by microRNAs (miRs), such as miR-145, whose dysregulation has been related to cancer. The aims of this work were to evaluate in EOC cells whether NGF/TRKA decreases miR-145 levels, and the effect of miR-145 upregulation. The levels of miR-145-5p were assessed by qPCR in ovarian biopsies and ovarian cell lines (human ovarian surface epithelial cells (HOSE), A2780 and SKOV3) stimulated with NGF. Overexpression of miR-145 in ovarian cells was used to evaluate cell proliferation, migration, invasion, c-MYC and VEGF protein levels, as well as tumor formation and metastasis in vivo. In EOC samples, miR-145-5p levels were lower than in epithelial ovarian tumors. Overexpression of miR-145 decreased cell proliferation, migration and invasion of EOC cells, changes that were concomitant with the decrease in c-MYC and VEGF protein levels. We observed decreased tumor formation and suppressed metastasis behavior in mice injected with EOC cells that overexpressed miR-145. As expected, ovarian cell lines stimulated with NGF diminished miR-145-5p transcription and abundance. These results suggest that the tumoral effects of NGF/TRKA depend on the regulation of miR-145-5p levels in EOC cells, and that its upregulation could be used as a possible therapeutic strategy for EOC.

Citing Articles

Competing endogenous RNA networks in ovarian cancer: from bench to bedside.

Derogar R, Nejadi Orang F, Shadbad M EXCLI J. 2025; 24:86-112.

PMID: 39967908 PMC: 11830916. DOI: 10.17179/excli2024-7827.

Dr. Jekyll or Mr. Hyde: The multifaceted roles of miR-145-5p in human health and disease.

Rahman M, Ghorai S, Panda K, Santiago M, Aggarwal S, Wang T Noncoding RNA Res. 2024; 11:22-37.

PMID: 39736851 PMC: 11683234. DOI: 10.1016/j.ncrna.2024.11.001.

Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells.

Shender V, Anufrieva K, Shnaider P, Arapidi G, Pavlyukov M, Ivanova O Nat Commun. 2024; 15(1):5237.

PMID: 38898005 PMC: 11187153. DOI: 10.1038/s41467-024-49512-6.

The Immune Response of Cancer Cells in Breast and Gynecologic Neoplasms.

Rakoczy K, Kaczor J, Soltyk A, Szymanska N, Stecko J, Drag-Zalesinska M Int J Mol Sci. 2024; 25(11).

PMID: 38892394 PMC: 11172873. DOI: 10.3390/ijms25116206.

Nerve Growth Factor and the Role of Inflammation in Tumor Development.

Ferraguti G, Terracina S, Tarani L, Fanfarillo F, Allushi S, Caronti B Curr Issues Mol Biol. 2024; 46(2):965-989.

PMID: 38392180 PMC: 10888178. DOI: 10.3390/cimb46020062.

References

Dolle L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V, Hondermarck H . Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets. 2004; 4(6):463-70. DOI: 10.2174/1568009043332853. View

Zhang S, Pei M, Li Z, Li H, Liu Y, Li J . Double-negative feedback interaction between DNA methyltransferase 3A and microRNA-145 in the Warburg effect of ovarian cancer cells. Cancer Sci. 2018; 109(9):2734-2745. PMC: 6125441. DOI: 10.1111/cas.13734. View

Sticht C, de la Torre C, Parveen A, Gretz N . miRWalk: An online resource for prediction of microRNA binding sites. PLoS One. 2018; 13(10):e0206239. PMC: 6193719. DOI: 10.1371/journal.pone.0206239. View

Zheng T, Li D, He Z, Zhao S . miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. Cancer Cell Int. 2019; 19:250. PMC: 6767650. DOI: 10.1186/s12935-019-0943-6. View

Gupta G, Massague J . Cancer metastasis: building a framework. Cell. 2006; 127(4):679-95. DOI: 10.1016/j.cell.2006.11.001. View

Retamales-Ortega R, Orostica L, Vera C, Cuevas P, Hernandez A, Hurtado I . Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer. Int J Mol Sci. 2017; 18(3). PMC: 5372523. DOI: 10.3390/ijms18030507. View

Wang Y, Lee C . MicroRNA and cancer--focus on apoptosis. J Cell Mol Med. 2009; 13(1):12-23. PMC: 3823033. DOI: 10.1111/j.1582-4934.2008.00510.x. View

Zhang X, Wu J . Prognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysis. Prostate Int. 2015; 3(3):71-4. PMC: 4588372. DOI: 10.1016/j.prnil.2014.09.001. View

Maggirwar S, Sarmiere P, Dewhurst S, Freeman R . Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J Neurosci. 1998; 18(24):10356-65. PMC: 6793355. View

10.

Tang L, Wei D, Yan F . MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer. Cancer Gene Ther. 2016; 23(8):258-65. DOI: 10.1038/cgt.2016.27. View

11.

Rodriguez D, Tapia J, Fernandez J, Torres V, Munoz N, Galleguillos D . Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. Mol Biol Cell. 2009; 20(8):2297-310. PMC: 2669036. DOI: 10.1091/mbc.e08-09-0939. View

12.

Urzua U, Tapia V, Geraldo M, Selman A, Vega M, Romero C . Nerve growth factor stimulates cellular proliferation of human epithelial ovarian cancer. Horm Metab Res. 2012; 44(9):656-61. DOI: 10.1055/s-0032-1304617. View

13.

Chen S, Chang R, Lin L, Chern C, Tsai H, Wen Z . MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities. Int J Environ Res Public Health. 2019; 16(9). PMC: 6539609. DOI: 10.3390/ijerph16091510. View

14.

Li J, Lu J, Ye Z, Han X, Zheng X, Hou H . 20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer. Oncotarget. 2017; 8(32):53375-53386. PMC: 5581117. DOI: 10.18632/oncotarget.18482. View

15.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

16.

Dubois-Camacho K, Diaz-Jimenez D, De la Fuente M, Quera R, Simian D, Martinez M . Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis. Front Immunol. 2019; 10:2449. PMC: 6879552. DOI: 10.3389/fimmu.2019.02449. View

17.

Garrido M, Vera C, Vega M, Quest A, Romero C . Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells. Ther Adv Med Oncol. 2018; 10:1758835918770984. PMC: 5949935. DOI: 10.1177/1758835918770984. View

18.

Li G, Qin X, Song H, Li Y, Qiu Y, Cui S . Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3. J Cell Physiol. 2019; 234(12):22331-22342. DOI: 10.1002/jcp.28799. View

19.

Xu M, Mo Y . The Akt-associated microRNAs. Cell Mol Life Sci. 2012; 69(21):3601-12. PMC: 3475760. DOI: 10.1007/s00018-012-1129-8. View

20.

Sun H, Cui R, Zhou J, Teng K, Hsiao Y, Nakanishi K . ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5. Cancer Cell. 2016; 30(5):723-736. PMC: 5127275. DOI: 10.1016/j.ccell.2016.10.001. View